In the postmenopausal population, the assessment of Ca-125 with complementary markers like Human Epididymis protein 4 (HE4) and Carcinoembryonic Antigen (CEA) enhances both the sensitivity and specificity of tumor marker accuracy in the diagnostic process. Here, WFDC2 is linked to neoplasm.